这一页讲「生物活性肽」（bioactive peptides）这个术语，以及它在中文语境里被放大的原因。所谓生物活性肽，指的是在实验体系中观察到某种可测量效应的肽段，比如能与某个受体结合、能抑制某个酶的活性、或在细胞实验中改变了某个读数。这个定义的关键词是「在实验体系中」：bioactive 描述的是一次测定（assay）的结果，不是某种物质天然携带的属性标签。我写这一页，是因为很多中文材料把这两层直接合并，读者看到「活性」两个字就理解成了健康效应。
本页的边界先说清楚：不提供功效结论（no efficacy claim），不提供人体剂量（no dosing），不对任何产品、来源或使用方式作推荐。食物来源的蛋白水解物（protein hydrolysates）在文献里是研究材料，本页只描述这类研究怎么设计、报告了什么、局限在哪里。所有文献描述都会带上实验体系；细胞或动物实验的发现不一定能外推到人体结局。基础术语请见peptides 中文释义，化学机制见peptide chemistry 入门。
English gloss: this page is about the term bioactive peptide and about why the word activity is stretched so far in chinese-language material. Bioactive simply means that some measurable effect was observed in a test system: the chain bound a target, changed the rate of an enzyme reaction, or moved a readout in a cell experiment. It is a label for a result, not a property that a substance carries around with it. The pages that interest me here describe food protein hydrolysates as a research material: a protein is cut with enzymes, the resulting mixture is separated, fractions are screened, and the sequences in active fractions are identified by mass spectrometry. The endpoint of that chain is a reading under stated conditions, and it is not a statement about any food or any person.
生物活性肽的来源与研究材料
文献里被研究的多肽来源大致有三类。第一类是内源性的（endogenous），即生物体内本身产生的信号肽与调节肽，这类研究关注的是它们在体内的生成、受体与清除途径。第二类是来源于食物的（food-derived），最常见的是蛋白质水解物（protein hydrolysates）：用酶把食物蛋白切开，得到一批长短不一的肽段，再去测其中哪些片段在实验体系中表现出某种活性。第三类是化学合成的（synthetic），序列由研究者设计，用来做结构-活性关系的对照实验。三类的研究逻辑完全不同，不能互相替代。
食物来源的研究尤其容易被误读，所以值得多说一句。这类研究的标准流程通常是：酶解得到混合物、用色谱分离成组分、对组分做体外活性测定（in vitro assay）、对显示活性的组分做质谱鉴定（mass spectrometry）以确定序列、最后用合成的同序列肽重复一遍测定。请注意这个链条的终点：终点是「某个序列在某套条件下给出了某个读数」，而不是「某种食物对人体有某种作用」。这两句话之间的距离，是整页内容里最需要读者记住的距离。
English gloss: peptide material in the literature comes from three places and the three are studied in different ways. Endogenous peptides are produced by an organism, and work on them asks how they are generated, which receptors they meet and how they are cleared. Food-derived peptides usually arrive as protein hydrolysates, meaning a food protein digested with enzymes into a mixture of fragments of many lengths. Synthetic peptides are designed by the investigator and used for structure-activity comparisons where the sequence is the variable. The food-derived route deserves care because its standard workflow ends in a screening result, not in an outcome: enzymatic digestion, chromatographic separation, in vitro screening of fractions, identification by mass spectrometry, and then a repeat test with a synthesised copy of the same sequence.
活性测定到底测了什么
体外活性测定（in vitro assay）是一个非常笼统的说法，底下有很多种完全不同的实验。结合实验（binding assay）测的是肽与靶标之间的亲和力（affinity）；酶活抑制实验测的是某个酶的催化速率在特定条件下下降了多少；细胞实验测的是加了肽之后某个细胞读数（比如报告基因表达、钙流、增殖指标）的变化；抗氧化类的化学测定测的则是肽在试管里对某个自由基探针的反应能力。这四类测的是四件不同的事，但都可能被中文材料概括成「有活性」三个字。
读这类报告时，有三个参数决定了结论的边界。第一是浓度（concentration）：任何活性都是在某个浓度下测到的，脱离浓度谈活性没有意义，文献里常见的 IC50 或 EC50 本身就是条件化的数值。第二是体系（system）：纯化蛋白、细胞裂解液、完整细胞、动物模型，每一级都会引入新的变量。第三是对照（control）：有没有阳性对照、有没有无关肽对照、有没有重复。这三项缺任何一项，那个「活性」就只是一个观察，不是一个可比较的结果。
English gloss: the phrase in vitro assay covers several very different experiments, and chinese material tends to collapse them into the single word huoxing. A binding assay measures the affinity between a peptide and a purified target. An enzyme inhibition assay measures how far the catalytic rate of one enzyme drops under a defined substrate concentration. A cell-based assay measures whether a cellular readout moved after the peptide was added. A chemical probe assay measures a reaction in a tube between the peptide and a radical or reducing reagent. Three parameters decide how far any of those results travel: the concentration at which the effect was seen, the level of the system, and whether positive and irrelevant-peptide controls were run with replication.
| 测定类型 assay | 实际测量的对象 | 结论能覆盖的范围 |
|---|---|---|
| binding 结合实验 | 肽与纯化靶标之间的亲和力 affinity / affinity between the peptide and a purified target | 只说明在该条件下测到相互作用 / only an interaction under those stated conditions |
| enzyme inhibition 酶抑制 | 特定酶的催化速率在给定底物下的变化 | 只说明该酶在该反应体系中的读数变化 |
| cell-based 细胞实验 | 加入肽后某个细胞读数的变化 | 说明细胞模型中的观察，不等于机体结局 |
| chemical probe 化学探针法 | 试管中肽对某个化学探针的反应能力 / a reaction between the peptide and a probe reagent in a tube | 属于化学条件下的现象，与生理结局无关 / a chemical observation, not a physiological outcome |
| animal model 动物模型 | 整体动物层面的指标变化 | 受物种与条件限制，不能等同人体结局 |
为什么 assay activity 不等于健康结局
这一段是本页的核心。从「试管里有活性」到「对人体产生某种健康结局」，中间隔着好几层需要各自证明的环节：这个肽在摄入或给予后是否保持完整（stability）、能否到达它 supposed 作用的位置（bioavailability）、在体内被代谢成什么（metabolism）、需要多大暴露量才能重现体外那个浓度（exposure）、以及长期安全性如何。每一层都是一个独立的研究问题，而且每一层都可能把上一层的结论全部否定。文献里把这串问题统称为从 in vitro 到 in vivo 的转化问题（translation gap）。
因此我在本页保留与全站一致的固定边界：findings in cell or animal studies may not translate to human outcomes。社区里流传的个人叙述（anecdotal user reports）属于另一类材料，它们能证明的是「有人这样写过」，不能证明「事情是这样」，我把它单独归档在reddit 讨论归档并标注为 anecdote。至于化学层面的构象与稳定性讨论，可以看化学与生物学交界处这一页。
English gloss: this section is the core of the page. Between activity in a tube and a health outcome in a person stand several questions that each need their own evidence: whether the peptide survives as the intact sequence, whether it reaches the compartment where the interaction was measured, what it is metabolised into, what exposure would be needed to reproduce the concentration used in the assay, and what the safety picture looks like. Any one of those can overturn the result that came before it, and the literature calls the whole problem the translation gap between in vitro and in vivo work. Animal models narrow the gap without closing it, which is why this site repeats that findings in cell or animal studies may not translate to human outcomes.
- 活性（activity）是一次测定的结果，必须连同浓度、体系与对照一起阅读。
- 从体外活性到人体结局之间隔着 stability、bioavailability、metabolism 与 exposure 等独立问题。
- 动物实验受物种与条件限制，findings in cell or animal studies may not translate to human outcomes。
- 本页不提供任何功效结论、剂量或使用建议，也不比较或推荐任何供应方。
Frequently asked questions
什么是生物活性肽（bioactive peptide）？
食物蛋白水解物研究是不是说明某种食物有保健作用？
IC50 或 EC50 这样的数值该怎么看？
本页会给出剂量或使用方式吗？
这里能查到价格或购买渠道吗？
References and public sources
Literature searches and public reference links. None of them confirms or denies any community claim filed elsewhere on this site.